Package 57237-274-24

{"route": ["ORAL"], "spl_id": "413db889-6bea-4815-b016-d619dba8029f", "openfda": {"nui": ["N0000175656", "N0000175462", "N0000009947"], "unii": ["2T8Q726O95"], "rxcui": ["199148"], "spl_set_id": ["bed2e227-8d36-40ea-bbbf-d8793bfda425"], "pharm_class_epc": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "240 mL in 1 BOTTLE (57237-274-24)", "package_ndc": "57237-274-24", "marketing_start_date": "20161121"}], "brand_name": "Lamivudine", "product_id": "57237-274_413db889-6bea-4815-b016-d619dba8029f", "dosage_form": "SOLUTION", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "57237-274", "generic_name": "Lamivudine", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamivudine", "active_ingredients": [{"name": "LAMIVUDINE", "strength": "10 mg/mL"}], "application_number": "ANDA077695", "marketing_category": "ANDA", "marketing_start_date": "20161121", "listing_expiration_date": "20261231"}